Abstract
Following the publication of this article the authors noted that the sentence on page 5 reading “The major response rate was 80% with no difference between patients with wild-type or mutated MYD 88” was incorrect, and should read as “The major response rate was 80% with no difference between patients with mild-type or mutated CXCR4”. The authors wish to apologise for any inconvenience caused. This has now been corrected in the HTML and PDF.
Original language | English (US) |
---|---|
Article number | 53 |
Journal | Blood cancer journal |
Volume | 9 |
Issue number | 7 |
DOIs |
|
State | Published - Jul 1 2019 |
ASJC Scopus subject areas
- Hematology
- Oncology